The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of plasmodium falciparum sporozoites

Cell

Volumn 70, Issue 6, 1992, Pages 1021-1033

  Cerami, Carla ^a   Frevert, Ute ^a   Sinnis, Photini ^a   Takacs, Bela ^b   Clavijo, Pedro ^a   Santos, Manuel J ^c   Nussenzweig, Victor ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR;

AMINO ACID COMPOSITION; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIGAND BINDING; LIVER CELL; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN BINDING; SPOROZOITE; TARGET CELL;

AMINO ACID SEQUENCE; ANIMAL; ANTIGENS, PROTOZOAN; BINDING SITES; CELL MEMBRANE; CELL POLARITY; HUMAN; LIVER; MICE; MICROVILLI; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN BINDING; RATS; RECEPTORS, CELL SURFACE; REPETITIVE SEQUENCES, NUCLEIC ACID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

PLASMODIUM FALCIPARUM;

EID: 0026795458     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(92)90251-7     Document Type: Article

References (65)

1. The protective antigen of rodent malarial sporozoites (Plasmodium berghei) is a differentiation antigen
2. Synthetic peptides from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium knowlesi recognize the human hepatoma cell line HepG2-A16 in vitro
3. Immunogenicity of synthetic peptides from the circumsporozoite protein of Plasmodium falciparum
4. Quantitation of malaria sporozoites transmitted in vitro during salivation by wild Afrotropical Anopheles
5. Fine specificity of monoclonal antibodies against the Plasmodium falciparum circumsporozoite protein: recognition of both repetitive and non-repetitive regions
6. Binding of malarial circumsporozoite protein to sulfatides and cholesterol-3-sulfate: dependency on disulfide bond formation between cysteines in region II
7. Regions of an Eimeria tenella antigen contain sequences which are observed in circumsporozoite proteins from Plasmodium ssp and which are related to the thrombospondin gene family
8. Antibody induced ultrastructural changes of malarial sporozoites
9. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum
10. Sequence variations in putative functional domains of the circumsporozoite protein of Plasmodium falciparum: implications for vaccine development
11. Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development
12. Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes
13. Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitope
14. Thrombospondins
15. Stagespecific expression and intracellular shedding of the cell surface transsialidase of Trypanosoma cruzi
16. The circumsporozoite gene of the Plasmodium cynomolgi complex
17. The circumsporozoite protein is the immunodominant surface antigen on the sporozoite
18. The T-cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development
19. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs
20. Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion
21. A malaria sporozoite surface antigen distinct from the circumsporozoite protein
22. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications
23. In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei from sporozoites
24. Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatides and has a sequence homology with other proteins that bind sulfated glycoconjugates
25. Properdin binds to sulfatide and has a sequence homology with other proteins that bind sulfate glycoconjugates
26. General method for the rapid solid-phase synthesis of a large number of peptides: specificity of antigen-antibody interaction at the level of individual amino acids
27. Isolation of rat hepatocyte plasma membranes: presence of three major domains
28. Direct demonstration of the lectin activity of gp90MEL, a lymphocyte homing receptor
29. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen
30. Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii: a rodent model for examining antimalarial sporozoite vaccines
31. Structure of the circumsporozoite gene of Plasmodium malariae
32. Circumsporozoite protein gene from Plasmodium brasilianum
33. Disulfide cross-linking of Escherichia coli ribosomal proteins with 2-iminothiolane (methyl 4-mercaptobutyrimide): evidence that the cross-linked protein pairs are formed in the intact ribosomal subunit
34. Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein
35. Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax
36. An ultrastructural study on the role of Kupffer cells in the process of infection by Plasmodium berghei sporozoites in rats
37. Von Willebrand factor and platelet function
38. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax
39. Rationale for the development of an engineered sporozoite malaria vaccine
40. 20 KDa homologous restriction factor of complement resembles T cell activating protein
41. Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates
42. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infections
43. The properdin-like type I repeats of human thrombospondin contain a cell attachment site
44. Cell-adhesive motif in region II of malarial circumsporozoite protein
45. Reversed-phase high-performance liquid chromatography: preparative purification of synthetic peptides
46. The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids
47. Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids
48. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite
49. An estimation of the number of malaria sporozoites ejected by a feeding mosquito
50. Host cell invasion by Apicomplexa an expression of the parasite's contractile system?
51. Structural similarities among the protective antigens of sporozoites from different species of malaria parasites
52. Direct infection of hepatocytes by sporozoites of Plasmodium berghei
53. The role of cell motility in host cell invasion by the Apicomplexa
54. The development and routine application of high density exoerythrocytic-stage cultures of Plasmodium berghei
55. Intercellular communication and cell-cell adhesion
56. Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies
57. New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein
58. Preparation of clinical grade proteins produced by recombinant DNA technologies
59. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications
60. The GPIIβ-IIα-like complex may function as a human melanoma cell adhesion receptor for thrombospondin
61. Studies on the motility of Plasmodium sporozoites
62. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei: in vitro effects of immune serum on sporozoites
63. Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei
64. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria